E-cigarettes: A proving quitting tool that still carries health risks
Nicotine e-cigarettes may be more effective at quitting smoking than traditional methods
A new study published in the journal Addiction found that nicotine e-cigarettes are more effective for smoking cessation than traditional methods like nicotine patches or gum. Researchers at Oxford aim to lay to rest claims that evidence is mixed; their meta-analysis shows clear and consistent data supporting e-cigarettes as a successful aid for stopping smoking. A 2024 review noted that an additional 2 to 5 people out of every 100 successfully quit smoking when using e-cigarettes compared to other replacement therapies.
While not risk-free, switching from combustible tobacco to e-cigarettes significantly reduces exposure to cancer-causing chemicals. In this connection, Angela Difeng Wu, senior researcher and lecturer at the Nuffield Department of Primary Care Health Sciences at Oxford said: “We hope this overview and Evidence and Gap Map can lay to rest some claims that evidence is mixed regarding the impacts of nicotine e-cigarettes on smoking abstinence.”
Health risks and scientific gaps
Despite the reduction in toxins compared to tobacco, a February 2026 study confirmed that vapers are still exposed to carcinogenic chemicals. Because e-cigarettes are relatively new and constantly changing, long-term health impacts remain both evolving and inconclusive. Furthermore, the Oxford review found that current data regarding serious health complications is still insufficient to draw firm conclusions.
Global concerns and impact on children
The World Health Organization (WHO) remains a vocal critic, arguing that these products are hooking kids on nicotine and undermining years of tobacco control progress. Estimates for 2025 show over 100 million vapors globally, including 15 million children aged 13-15. Ongoing controversies and perceived uncertainties continue to hamper international health policies and individual clinical decisions.
-
Eli Lilly expands $2.75B AI-enabled drug discovery deal with Insilico Medicine
-
London sewage detects polio weeks after funding drop
-
COVID-19 ‘Cicada’ variant: Here’s everything to know
-
Eye drops made from pig body fluid could revolutionize cancer treatment, new study says
-
Paul Conyngham uses ChatGPT, AlphaFold to develop a life-saving cancer vaccine for his dog
-
'Cicada' COVID variant detected in multiple countries as experts study mutation risks
-
Metformin’s hidden brain pathway uncovered after 60 years
-
New study shows how an extra 11 minutes of sleep each night reduces heart attack risk
-
Insulin pills near reality, promising injection-free diabetes care
-
A smarter approach to eating: Why isn't calorie counting enough?
-
Cutting sweet cravings doesn't reduce cravings or improve health: Scientists debunk myth
-
Argentina exits World Health Organization following US lead: What it means for public health and diplomacy?
